ArticlesBestJobs poll: Romanians want to rest more this year, after a difficult 2021
ArticlesPwC forecasts: Global economy will advance by 4.5% in 2022 if the impact of Omicron is limited
ArticlesEastern Europe Eyed as the Next Silicon Valley: A Chance for Poland to Rise
ArticlesMechanisms for labor management in the automotive industry - fiscal and legal implications
ArticlesHorvath Study: Packaging industry to grow by 30% to $ 1 trillion in 2025
InterviewsCHEP, 10 years of leading the transition to the circular economy
InterviewsRemain committed, agile, efficient, and focussed on your targets
InterviewsPower management is at the heart of digital transformation
InterviewsThe combination of sustainability and digital technologies is key to igniting future competitiveness
NewsAutonomous will acquire Tiriac Operating Lease, the operational leasing division of the Tiriac Group
NewsMyFrenchFilmFestival, the online festival dedicated to French cinema, returns to Orange TV Go
NewsFlanco launches the longest free return period in electro-IT retail in Romania
Also, Biofarm is going to make investments of over 47 million lei this year
The Romanian medicine manufacturer Biofarm (stock symbol BIO) aims at a 15% increase in turnover in 2021. The company aims to obtain a value of sales revenues of over 251 million lei.
For more information, please see the Romanian version of the article, here.
